Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
Cancer Communications · 2025-08 · 45 (8) · 888-913
DOI: 10.1002/cac2.70027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 29.04.2025. Verfasst von Wenpeng Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Neutrophils, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, R&D Program of Beijing Municipal Education Commission.
Abstract (Originalsprache)
Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their short half‐life, especially as there is limited information on the role of intratumoral neutrophils. Recent studies on their prominent role in cancer have led to a paradigm shift in our understanding of the functional diversity of neutrophils. These studies highlight that neutrophils have emerged as key components of the tumor microenvironment, where they can play a dual role in promoting and suppressing cancer. Moreover, several approaches to therapeutically target neutrophils have emerged, and clinical trials are investigating their efficacy. In this review, we discussed the involvement of neutrophils in cancer initiation and progression. We summarized recent advances in therapeutic strategies targeting neutrophils and, most importantly, suggested future research directions that could facilitate the manipulation of neutrophils for therapeutic purposes in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- R&D Program of Beijing Municipal Education Commission
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Cai, W., Fan, T., Xiao, C., Deng, Z., Liu, Y., Li, C., & He, J. (2025). Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor. Cancer Communications, 45(8), 888-913. https://doi.org/10.1002/cac2.70027
Vancouver
Cai W, Fan T, Xiao C, Deng Z, Liu Y, Li C, et al. Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor. Cancer Communications. 2025;45(8):888-913. doi:10.1002/cac2.70027
BibTeX
@article{Cai2025,
author = {Cai, Wenpeng and Fan, Tao and Xiao, Chu and Deng, Ziqin and Liu, Yixiao and Li, Chunxiang and He, Jie},
title = {Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor},
journal = {Cancer Communications},
year = {2025},
volume = {45},
number = {8},
pages = {888--913},
doi = {10.1002/cac2.70027}
}
EUVIMED